Patient-Reported Outcomes after Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Patients with Relapsed/ Refractory Large B-Cell Lymphomas

被引:0
|
作者
Balitsky, Amaris K. [1 ,2 ]
Pond, Gregory R. [2 ]
Fraser, Graeme [1 ,2 ]
Kouroukis, Tom [1 ,2 ]
Foley, Stephen Ronan [1 ,2 ]
机构
[1] Hamilton Hlth Sci, Juravinski Canc Ctr, Hamilton, ON, Canada
[2] McMaster Univ, Dept Oncol, Hamilton, ON, Canada
关键词
D O I
10.1182/blood-2022-165674
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:8036 / 8037
页数:2
相关论文
共 50 条
  • [21] Factors Associated with Costs in Chimeric Antigen Receptor T-Cell Therapy for Patients with Relapsed/Refractory B-Cell Malignancies
    Zhu, Feng
    Wei, Guoqing
    Zhang, Mingming
    Zhao, Houli
    Wu, Wenjun
    Yang, Luxin
    Hu, Yongxian
    Huang, He
    CELL TRANSPLANTATION, 2020, 29
  • [22] Patient selection for chimeric antigen receptor (CAR) T-cell therapy for aggressive B-cell non-Hodgkin lymphomas
    Johnson, P. Connor
    Abramson, Jeremy S.
    LEUKEMIA & LYMPHOMA, 2020, 61 (11) : 2561 - 2567
  • [23] Update on CAR T-Cell Therapies for Relapsed/Refractory B-Cell Lymphomas
    Schuster, Stephen J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (5.5): : 622 - 624
  • [24] Early toxicity and clinical outcomes after chimeric antigen receptor T-cell (CAR-T) therapy for lymphoma
    Brammer, Jonathan E.
    Braunstein, Zachary
    Katapadi, Aashish
    Porter, Kyle
    Biersmith, Michael
    Guha, Avirup
    Vasu, Sumithira
    Yildiz, Vedat O.
    Smith, Sakima A.
    Buck, Benjamin
    Haddad, Devin
    Gumina, Richard
    William, Basem M.
    Penza, Sam
    Saad, Ayman
    Denlinger, Nathan
    Vallakati, Ajay
    Baliga, Ragavendra
    Benza, Raymond
    Binkley, Philip
    Wei, Lai
    Mocarski, Mason
    Devine, Steven M.
    Jaglowski, Samantha
    Addison, Daniel
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (08)
  • [25] Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Multiply Relapsed or Refractory Adult Large B-Cell Lymphoma
    Lin, John K.
    Muffly, Lori S.
    Spinner, Michael A.
    Barnes, James, I
    Owens, Douglas K.
    Goldhaber-Fiebert, Jeremy D.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (24) : 2105 - +
  • [26] Patient-Reported Outcomes at Time of CAR-T Cell Therapy
    Mullane, Erin
    Jones, Taylor
    Voutsinas, Jenna
    Wu, Qian Vicky
    Loggers, Elizabeth
    Fann, Jesse
    Maloney, David G.
    Bar, Merav
    BLOOD, 2020, 136
  • [27] Communication About Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
    Dhawale, Tejaswini
    Johnson, P. Connor
    Boateng, Kofi
    Barata, Anna
    Traeger, Lara
    Nelson, Ashley M.
    Lavoie, Mitchell W.
    Holmbeck, Katherine
    Choe, Joanna
    Nabily, Anisa
    Tripathi, Astha
    Amonoo, Hermioni L.
    Frigault, Matt
    El-Jawahri, Areej
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (04): : 402.e1 - 402.e12
  • [28] CAR T-Cell Therapy for Relapsed/Refractory Aggressive Large B-Cell Lymphoma
    Gideon, Jacklyn
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2022, 26 (06) : 597 - 601
  • [29] Outcomes after chimeric antigen receptor T-cell therapy across large B-cell lymphoma subtypes
    Bourlon, Christianne
    Roddie, Claire
    Menne, Tobias
    Norman, Jane
    O'Reilly, Maeve
    Gibb, Adam
    Besley, Caroline
    Chaganti, Sridhar
    Arias, Carlos Gonzalez
    Jones, Ceri
    Dikair, Abdalla
    Allen, Sharon
    Seymour, Frances
    Osborne, Wendy
    Mathew, Amrith
    Townsend, William
    Patten, Piers E. M.
    Thoulouli, Eleni
    Abdulgawad, Ahmed
    Lugthart, Sanne
    Sanderson, Robin
    Kirkwood, Amy A.
    Kuhnl, Andrea
    HAEMATOLOGICA, 2024, 109 (08) : 2716 - 2720
  • [30] Correlation of Peripheral Chimeric Antigen Receptor T-cell (CAR-T Cell) mRNA Expression Levels with Toxicities and Outcomes in Patients with Diffuse Large B-cell Lymphoma
    Messerli, Christian
    Wiedemann, Gertrud
    Porret, Naomi
    Nagler, Michael
    Seipel, Katja
    Jeker, Barbara
    Novak, Urban
    Zeerleder, Sacha
    Bacher, Ulrike
    Pabst, Thomas
    TURKISH JOURNAL OF HEMATOLOGY, 2023, 40 (03) : 187 - 196